... membrane in 14 patients with EmeryDreifussmusculardystrophy Nat Genet 12, 254–259 Manilal S, thi Man N, Sewry CA & Morris GE (1996) The EmeryDreifussmusculardystrophy protein, emerin, is ... on chromosome Xq28 and mutations within this gene give rise to X-linked EmeryDreifussmusculardystrophy (X-EDMD), a neuromuscular condition with an associated life-threatening cardiac conduction ... death-promoting transcriptional repressor, is disrupted by a missense mutation that causes EmeryDreifussmusculardystrophy Eur J Biochem 271, 1035–1045 Holaska JM, Lee KK, Kowalski AK & Wilson KL (2003)...
... of musculardystrophy The other major types of musculardystrophy include: • • • • • Limb-girdle musculardystrophy Congenital musculardystrophy Oculopharyngeal musculardystrophy Distal muscular ... musculardystrophy Distal musculardystrophy Emery- Dreifussmusculardystrophy Limb-girdle musculardystrophy Muscles usually affected first by this form of musculardystrophy include: • • Hips Shoulders ... features of Emery- Dreifuss MD Emery- Dreifuss MD usually begins in the childhood to early teen years and progresses slowly Causes Musculardystrophy is a general term for a group of inherited diseases...
... oculopharyngeal musculardystrophy Neuromusc Disord 7, 63–69 ´ 16 Calado A, Tome FMS, Brais B, Rouleau GA, Kuhn U, ¨ Wahle E & Carmo-Fonseca M (2000) Nuclear inclusions in oculopharyngeal musculardystrophy ... References Scheibel T & Buchner J (2006) Protein aggregation as a cause for disease In Molecular Chaperones in Health and Disease; Handbook of Experimental Pharmacology (Gaestel M, ed.), pp 199–219 ... Trinucleotide repeats and neurodegenerative disease Brain 127, 2385–2405 Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer’s and Parkinson’s diseases Nature Cell Biol 6, 1054–1061...
... heart in the mdx mouse model of Duchenne MuscularDystrophy PLoS One 2010, 5:e11220 Bushby K, Lochmuller H, Lynn S, Straub V: Interventions for muscular dystrophy: molecular medicines entering ... stimulation[11,12,25] For this proof-of-principle study, we did not include additional models of musculardystrophy or wild-type mice However, we can compare the contractile response to our previous ... failure stemming from a variety of etiologies, NBD treatment may be useful beyond the field of musculardystrophy Acknowledgements This study was supported by a grant from the National Institutes...
... heart in the mdx mouse model of Duchenne MuscularDystrophy PLoS One 2010, 5:e11220 Bushby K, Lochmuller H, Lynn S, Straub V: Interventions for muscular dystrophy: molecular medicines entering ... stimulation[11,12,25] For this proof-of-principle study, we did not include additional models of musculardystrophy or wild-type mice However, we can compare the contractile response to our previous ... failure stemming from a variety of etiologies, NBD treatment may be useful beyond the field of musculardystrophy Acknowledgements This study was supported by a grant from the National Institutes...
... of donor nuclei in a Duchenne musculardystrophy patient receiving bone marrow transplantation J Clin Invest 2002, 110:807-814 Cooke R: Stem cells aimed at muscular dystrophy: evidence suggests ... marrow transplantation in a patient with Diamond-Blackfan anemia with co-existing Duchenne muscular dystrophy: a case report Journal of Medical Case Reports 2011 5:216 Competing interests The ... MC, van Paassen HM, van Broeckhoven C, Pearson PL, van Ommen GJ: Topography of the Duchenne musculardystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications...
... Duchenne musculardystrophy using Multiplex Ligation- dependent Probe Amplification” CHAPTER INTRODUCTION 1.1 Duchenne musculardystrophy 1.1.1 Characteristics of DMD Duchenne musculardystrophy ... complex (DGC) in skeletal muscular [4] 12 Figure 5: The steps in PCR 15 Figure 6: Test hybridization on a metaphase from the 18 Duchenne musculardystrophy carrier [29] ... in the 1860s Although the disease was discovered a long time ago, as recently as the early 1980s, people still did not understand the cause of any form of musculardystrophy In 1986, researchers...
... Duchenne musculardystrophy using Multiplex Ligation- dependent Probe Amplification” CHAPTER INTRODUCTION 1.1 Duchenne musculardystrophy 1.1.1 Characteristics of DMD DMD is an X-linked recessive disease ... phát bệnh nhân có đột biến lặp đoạn exon 11-20 51-60 gen dystrophy Kỹ thuật MLPA thực theo khuyến nghị nhà sản xuất PREFACE Duchenne musculardystrophy (DMD) is one of the most common fatal genetic ... TÓM TẮT Bệnh loạn dưỡng Duchenne (Duchenne Muscular Dystrophy- DMD) bệnh di truyền lặn liên kết với nhiễm sắc thể X gây đột biến gen dystrophin.Theo...
... complicated hepatic hydatid disease after surgical intervention Endoscopy 2001, 33:858-63 Koksal N, Muftuoglu T, Gunerhan Y, et al Management of intrabiliary ruptured hydatid disease of the liver Hepatogastroenterology ... the management of hepatobiliary hydatid disease J Clin Gastroenterol 2002, 35:160-74 http://www.medsci.org Int J Med Sci 2011, 320 21 Milicevic H Hydatid disease In: Blumgart L, Fong Y, editors ... bleeding and biliary leakage from liver residual surface after total pericystectomy for hydatid disease. by Cois A, Forty-five patients underwent total pericystectomy and liver residual surface...
... Int J Med Sci 2011, (BMSs) in patients with symptomatic coronary artery disease of simple to moderate complexity (1-3) The use of the Zotarolimus-eluting stent (ZES; Medtronic ... Santa Rosa, CA) for treating single de novo lesions in patients with symptomatic coronary artery disease has been examined in the first four trials of the ongoing ENDEAVOR clinical trials program ... the rates of clinical and angiographic restenosis in patients with symptomatic coronary artery disease (CAD; 4) Also the safety and efficacy of Paclitaxel-eluting stent (PES; Taxus, Boston Scientific...
... report the 24-month outcomes of unselected patients in southern Turkey who had coronary artery disease that was treated with either the SES or the PES METHODS Patient Population The study population ... consecutive series of all patients who had undergone coronary stent implantation for coronary artery disease between February 2005 and March 2007; 103 of the patients received the SES (CYPHER; Cordis ... Natick, Massachusetts) Patients were eligible for enrollment if there was symptomatic coronary artery disease or positive functional testing, and angiographic evidence of a target lesion stenosis of...
... herniations, most published studies have focused on the use of PLDD for the treatment of lumbar disc disease Thoracic discogenic pain or herniation causing neural impingement is less common than that ... thoracic region In order to assess the efficacy and safety of PLDD for the treatment of thoracic disc disease, we performed a study of ten patients with thoracic discogenic pain who were unresponsive ... postoperatively Note that remaining patients reported minimal or no improvement Discussion Thoracic disc disease is much less common than that of lumbar and cervical discs However, certain types of impact,...
... obstructive pulmonary disease worldwide Monaldi Archives for Chest Disease 2001; 56: 261-264 Anto JM, Vermeire P, Vestbo J, Sunyer J Epidemiology of chronic obstructive pulmonary disease European ... understood and the healthcare costs associated with the disease are poorly characterized Few studies have attempted to quantify the impact of the disease on patient health, the healthcare system, caregivers ... very expensive disease to treat as well as costly in regard to premature morbidity and mortality, it is imperative that we develop a thorough understanding of the dimensions of this disease, both...
... ICAM-1 The outcome of the PCA of the radical data, data concerning the degree of arteriosclerotic disease and some relevant clinical data are shown in Figure In order to increase the lucidity of ... stenosis was associated with higher MMP-9 values, suggesting that a more severe atherosclerotic disease causes elevated MMP-9 levels Inhibition of MMP-9 in conjunction with these operations might ... correlation was found between the expression of ICAM-1 and the severity of symptomatic carotid disease [26] Oxidised, low-density lipoprotein (oxLDL) is found within the atherosclerotic blood...
... Alzheimer disease patients contain cytoskeletal components Proc Natl Acad Sci U S A 1985; 82: 3916-20 Mori H, Kondo J, Ihara Y Ubiquitin is a component of paired helical filaments in Alzheimer's disease ... Alzheimer disease brains Proc Natl Acad Sci U S A 1987; 84: 3033-6 Perry G, Cras P, Siedlak SL, et al Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease ... cycle control, in Alzheimer's disease Aging Cell 2003; 2: 105-10 Ogawa O, Zhu X, Lee HG, et al Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?...
... 12.0 software The association between the +294T/C polymorphism and serum lipids, coronary heart disease, and body mass index (BMI) was calculated using the Student’s t-test analysis with genotype ... Weinberg Equilibrium Overall the C allele frequency was higher in patients with coronary heart disease than in those without, but this difference was not statistically significant The plasma ... significantly lower VLDL In the entire group no significant interaction between genotype and coronary heart disease could be detected Eliminating patients with diabetes mellitus or triglycerides higher than...
... patients, or continued to slow liver disease progression without clearing the virus (Figure 1A) The benefits of maintenance therapy on the outcome of HCV-associated liver disease are currently under investigation ... hepatitis C depends on multiple parameters, including a precise assessment of the severity of liver disease and of its foreseeable outcome, the presence of absolute or relative contra-indications ... of a sustained virological response, of the order of 40% to 50%, a precise assessment of liver disease prognosis by means of a liver biopsy or a non-invasive method based on serological markers...